TABLE 1

Clinical characterization of study populations

Hong Kong
Korea SNUH
Korea KHGS
Type 2 diabetesControl subjectsType 2 diabetesControl subjectsType 2 diabetesControl subjects
n1,4811,5307616327991,516
Men/women598/883703/827354/407287/345428/371805/711
Age (year)49.7 ± 13.725.3 ± 14.459.2 ± 9.964.7 ± 3.656.1 ± 8.655.8 ± 8.7
AAD (year)43.6 ± 13.750.0 ± 10.152.8 ± 9.2
BMI (kg/m2)25.1 ± 4.221.0 ± 3.724.5 ± 2.923.6 ± 3.125.5 ± 3.324.2 ± 3.2
Fasting glucose (mmol/l)4.8 ± 0.44.9 ± 0.54.6 ± 0.4
Glucose at 120 min (mmol/l)5.6 ± 1.25.8 ± 1.2
Fasting insulin (pmol/l)39.0 (37.6–40.4)41.7 (40.1–43.3)39.3 (38.2–40.5)
Insulin at 120 min (pmol/l)236.7 (228.1–245.5)100.4 (95.8–105.1)
HOMA-IR1.4 (1.3–1.4)1.5 (1.5–1.6)1.3 (1.3–1.4)
HOMA-β103.1 (99.3–107.0)102.9 (98.5–107.5)125.6 (121.4–130)
Obesity (%)46.813.338.233.154.339.0
Metabolic syndrome (%)57.92.468.623.767.121.6
  • Data are means ± SD, geometric mean (95% CI), or percent.